Curetis is not your typical biotech start-up. We are rather a newcomer with many years of multi-disciplinary expertise. Over the past years we have created a healthy growth story. We have convinced our customers and partners, with our pioneering spirit, coupled with the simple aspiration „We care for Diagnostics“, our engineering prowess, and molecular biology and microbiological expertise.
We are not a typical R&D driven company. We rather put our focus on commercial product development. We listen carefully and flexibly react to market and customer demands and needs. We strive to address these by way of pragmatic and intelligent solutions such as Unyvero.
Subscribe to Curetis Newsletter
Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018
Curetis’ Subsidiary Ares Genetics Initiates Development of AI-Powered Infectious Disease Test
BOA 2018, British Orthopaedic Association - Birmingham, United Kingdom - September 25 to 28, 2018
ID Week - Infectious Disease 2018 - San Fransisco, USA - October 3 to 7, 2018